News

Press Releases

Viscira® Releases 2016 Vilumina™ Video Demo Reel for Life Sciences Clients

 

Viscira, a leading provider of digital marketing solutions and software products for the life sciences industry, recently released its 2016 Vilumina™ video demo reel for its life sciences clients. This new, one-and-a-half-minute video includes highlights of Viscira’s cutting-edge work, while demonstrating the company’s sophisticated Hollywood-style video production capabilities.

The demo reel effectively showcases Viscira’s breadth of video expertise from live-action video to documentary-style features to patient testimonials. One of Viscira’s core Vilumina solutions is its enhanced KOL (Key Opinion Leader) video module.

This broadcast-quality video solution integrates full-body, green-screen KOL commentary with cinematically-rich digital content, including 2D and 3D animation, dynamic motion graphics and other creative elements. In addition to green screen shoots, Viscira can also produce enhanced KOL videos using on-location shoots, depending on the program creative concept.

Similar to the production process used in the film industry, Viscira manages all steps of the video creation, from script and storyboard development to video shoot execution, and then to final editing and post-production.

“We wanted our new Vilumina demo reel to showcase the company’s sophisticated video capabilities, and the depth and breadth of our team’s expertise,” explained Marlon McKenney, Director of Motion Graphics at Viscira. “We recognize the importance of video as a communication tool in our industry, and we continue to innovate to ensure that our programs have maximum impact. We are proud of the fact that we have the diverse skill sets needed to do all of our video work in-house.”

The 2016 demo reel is now being released to many existing and prospective Viscira clients. It is already receiving strong praise, with many referring to it as another impressive display of the company’s distinctive digital work.

Click here to read full article.

Viscira® 3D Animation for Roche Receives Communicator Award of Distinction

 

The Communicator Awards, one of the most prestigious and competitive award programs honoring creative excellence for marketing and communication solutions, draws over 6,000 entries from across the US and worldwide. It recently named Viscira a Silver winner for the company’s 3D animation video program designed to educate health care professionals (HCPs) about idiopathic pulmonary fibrosis (IPF), a respiratory disease. The award was given in the area of video/film in pharmaceuticals within the specialty category of animation use.

IPF is a chronic and ultimately fatal disease characterized by a progressive decline in lung function. The primary objective of the animation video program developed for Roche was to educate HCPs on the mechanism of disease and to highlight the human impact of the disease on patients with IPF. The video was initially deployed at the ERS (European Respiratory Society) International Conference last September in Amsterdam.

This interactive MOD animation highlights the pathological features of IPF and includes high-quality character animation. The piece was both highly cinematic and scientifically realistic. Hagop (Kane) Kaneboughazian, VP of Animation at Viscira, described the video as “Toy Story meets pharma”.

The Communicator Awards is in its 22nd season and is the leading international awards program in marketing and communications. The program is sanctioned and judged by the Academy of Interactive & Visual Arts (AIVA). AIVA members include executives from organizations such as Conde Nast, Disney, Estee Lauder, Lockheed Martin, MTV Networks, and Yahoo! 

James Rouse, Roche’s International Product Manager - IPF, commented on the award.  "Working with Viscira to produce this animation has been a great experience, and really helped attendees at the Congress to visualize how IPF progresses in the lungs."

Click here to read full article.

Sudler & Hennessey Group Acquires Viscira

Sudler & Hennessey Group, a leading global healthcare communications network, is pleased to announce the acquisition of Viscira, a leader in digital marketing and cutting-edge media in the healthcare space. Viscira develops visually-stunning, interactive solutions that provide unique, differentiated, and compelling communication delivery for the life sciences industry. These solutions help deliver healthcare information in very personal and immersive ways, and have a meaningful impact on the future of healthcare communication, education, and actual medical practice.

Through this transaction, Viscira brings deep technology expertise and transformative digital solutions to Sudler. When integrated with Sudler's full-service promotional and educational capabilities, strategic depth, and global reach, the combination provides clients with a uniquely creative and powerful healthcare communication offering. Viscira also gives the Sudler Group a strong geographic presence on the west coast of the US. Viscira has an established blue chip client base and serves 17 of the world's top 25 pharmaceutical companies comprising over 135 unique brands.

 "The addition of Viscira's cutting-edge expertise takes communications to a new level by adding virtual reality, highly acclaimed 3-D animation technology, gaming, and interactive digital applications. It provides the platform to visually combine science and creative beautifully, and to deliver content to all of our customers in extremely engaging ways," stated Louisa Holland, Co-CEO the Americas.

 With headquarters in San Francisco, and offices in New York and London, Viscira expects the Sudler partnership to accelerate future growth both domestically and globally. Sudler's expertise in brand strategy, product messaging, and medical content development will provide additional depth to Viscira in these areas.

 "We are very excited to become part of the Sudler & Hennessey Group and the broader WPP family. While Viscira has been a very successful independent company, this collaboration will enable us to speed our growth and provide a unique value proposition to life science clients," stated Dave Gulezian, CEO of Viscira. Gulezian added, "After starting in a small office with just a few people, this transaction also marks a significant milestone for the company as a result of the commitment and hard work of our employees over the years."

Click here to read full Sudler & Hennessey press release

Click here to read full WPP press release

Viscira® Leverages Latest Virtual Reality Technologies in Healthcare Communication and Education

What can you do with a plain old cardboard box? Google seems to have the answer. CNN recently featured a story about a baby who was born with a life-threatening heart and lung defect that doctors had never seen before.

With the help of Google Cardboard, a toy-like cardboard device retailing for less than $20 online, a team of surgeons was able to observe a 3D image of the baby’s heart from various angles - different from what can be viewed on a regular computer screen. The ability to virtually rotate around and examine the heart from every angle allowed the doctors to map out a surgical repair which ultimately saved her life. This new tool is the latest example of the potential for virtual reality technology to have a meaningful impact on the future of healthcare communication and education, and actual medical practice.

Viscira, a leading provider of digital marketing solutions and software products for the life sciences industry, has long recognized this opportunity and has been capitalizing on these advancements by offering innovative VR solutions for its clients that communicate healthcare information in very personal and immersive ways. One recent example was the development of a VR solution for a client using the Oculus Rift to simulate the impact of schizophrenia on a patient.

Donning the Oculus Rift goggles, a healthcare professional, caregiver or other user becomes completely immersed in a 3D environment that offers a full visual and auditory experience of what it might be like to be a schizophrenic patient. The intent with this simulated experience is for the user to develop more empathy for the patient and the various life challenges they face. This in turn helps to reinforce the need for active, consistent patient support and ongoing medication adherence, among other patient success factors (see accompanying video).

The company also recently deployed an engaging VR exhibit for a newly approved, novel medication for patients with high cholesterol. This interactive experience for a top-five biotech company focused on how this innovative therapy works in the body in combination with other cholesterol-lowering medicines, like statins, to further lower LDL levels.

Previously, Viscira also developed a virtual reality exhibit called “EyeMac” that enabled physicians to simulate the experience of having neovascular (wet) age-related macular degeneration (AMD). Physicians used special goggles to immerse themselves in several virtual scenarios from a first-person, patient perspective.

Dave Gulezian, President & CEO of Viscira, commented on the use of VR for developing innovative digital solutions for its clients. “From early in our company’s development, we recognized the potential for VR technology to change the way we communicate healthcare information, and educate healthcare professionals, patients and caregivers. Our ongoing focus on utilizing [the] latest VR technology, from inexpensive solutions like Google Cardboard, to the Oculus Rift, enables us to continue to provide unique and differentiated products for our industry.”

Viscira’s virtual and augmented reality solutions are just one example of many innovative, interactive software applications and digital solutions the company offers. Viscira’s strategic approach, combined with its delivery of cutting-edge products, has resulted in an impressive roster of industry-leading clients, including Genentech, AbbVie, Johnson & Johnson, GlaxoSmithKline, Novartis and Lilly.

Click here to read full article.

News by Year Press Releases - News page